GLPwatch
News
Detected changes across GLP-1 drugs — label updates, shortages, recalls, and new trials, newest first, each linked to source.
2026-08-26
- Ozempic FDA label updated (2026-01-30)
- Recall: SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, F…
- Recall: SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Inj…
- Recall: SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injec…
- Recall: SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only,…
- Recall: SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only,…
- Recall: SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Inj…
- Recall: SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous…
- Recall: SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx O…
- Recall: SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous…
- Recall: SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Inj…
- Recall: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx On…
- Liraglutide injection shortage status changed: Current → To Be Discontinued
- Trial NCT06719011 status changed: Recruiting → Completed
2026-08-22
- Trial NCT07754461 status changed: Not yet recruiting → Recruiting
- Trial NCT07693608 status changed: Not yet recruiting → Enrolling by invitation
- Trial NCT07438444 status changed: Recruiting → Active not recruiting
- Trial NCT05822544 status changed: Recruiting → Active not recruiting
- Trial NCT07613307 status changed: Not yet recruiting → Recruiting
- Trial NCT07313813 status changed: Active not recruiting → Completed
2026-08-05
- Trial NCT07553299 status changed: Not yet recruiting → Active not recruiting
- Trial NCT07218354 status changed: Not yet recruiting → Recruiting
- Trial NCT06715514 status changed: Recruiting → Active not recruiting
- Trial NCT06162715 status changed: Enrolling by invitation → Active not recruiting
- Trial NCT07221591 status changed: Active not recruiting → Completed
2026-07-31
- Mounjaro FDA label updated (2026-07-29)
- Trial NCT05882045 status changed: Active not recruiting → Completed
- Trial NCT06649344 status changed: Active not recruiting → Completed
- Trial NCT05929079 status changed: Active not recruiting → Completed
- Trial NCT07573163 status changed: Not yet recruiting → Recruiting
2026-07-10
- Trial NCT07619508 status changed: Active not recruiting → Completed
- Trial NCT07619495 status changed: Active not recruiting → Completed
- Trial NCT07357766 status changed: Not yet recruiting → Withdrawn
- Trial NCT07417618 status changed: Active not recruiting → Completed
- Trial NCT07605052 status changed: Not yet recruiting → Active not recruiting
- Trial NCT06077864 status changed: Active not recruiting → Completed
- Trial NCT07357740 status changed: Not yet recruiting → Withdrawn
2026-06-02
- Recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceutic…
- Trial NCT06408532 status changed: Not yet recruiting → Unknown
- Trial NCT06449703 status changed: Recruiting → Unknown
- Trial NCT05646199 status changed: Not yet recruiting → Unknown
- Trial NCT06422624 status changed: Not yet recruiting → Unknown
- Trial NCT06438146 status changed: Recruiting → Unknown
2026-05-30
- Trial NCT06948422 status changed: Recruiting → Active not recruiting
- Trial NCT07194317 status changed: Enrolling by invitation → Completed
- Trial NCT07564414 status changed: Not yet recruiting → Recruiting
- Trial NCT06952530 status changed: Recruiting → Active not recruiting
- Trial NCT06948435 status changed: Recruiting → Active not recruiting